A field trial to assess the effect of vaccination against feline herpesvirus, feline calicivirus and feline panleucopenia virus in 6-week-old kittens
- 31 March 2001
- journal article
- clinical trial
- Published by SAGE Publications in Journal of Feline Medicine and Surgery
- Vol. 3 (1), 17-22
- https://doi.org/10.1053/jfms.2000.0154
Abstract
A trivalent (feline panleucopenia, feline herpesvirus, feline calicivirus), modified live, commercially available cat vaccine was used at either 6, 9 and 12 weeks of age (early schedule) or 9 and 12 weeks of age (conventional schedule), and the serological response to vaccination was assessed. The level of maternally derived antibody present at 6 weeks of age was also established. The use of early vaccination at 6 weeks of age induced an antibody response to each virus by 9 weeks of age in a significant proportion of kittens compared with unvaccinated littermates. There was no difference between the conventionally and early-vaccinated groups in terms of antibody response to any antigen by 12 and 15 weeks of age.Keywords
This publication has 5 references indexed in Scilit:
- Detection of feline parvovirus in dying pedigree kittensVeterinary Record, 1998
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986
- A potency test for inactivated small animal parvovirus vaccines using chicksJournal of Biological Standardization, 1982
- Transmission of feline viral rhinotracheitisVeterinary Record, 1982
- Feline respiratory viruses—their prevalence in clinically healthy catsJournal of Small Animal Practice, 1974